Sandra Kurtin

1.3k total citations
78 papers, 884 citations indexed

About

Sandra Kurtin is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sandra Kurtin has authored 78 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 38 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Sandra Kurtin's work include Multiple Myeloma Research and Treatments (25 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Sandra Kurtin is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Sandra Kurtin collaborates with scholars based in United States, Canada and France. Sandra Kurtin's co-authors include Tomislav Dragovich, Daniel D. Von Hoff, David S. Mendelson, Axel Hoos, Kelly M. Richardson, Sara Tinsley, Pavani Chalasani, Beth Faiman, K Lilleby and Alan F. List and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Medicine.

In The Last Decade

Sandra Kurtin

70 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Kurtin United States 16 432 303 284 109 93 78 884
Nicole Onetto Canada 10 866 2.0× 459 1.5× 282 1.0× 174 1.6× 79 0.8× 13 1.6k
Ruben A. Saez United States 13 301 0.7× 145 0.5× 251 0.9× 69 0.6× 72 0.8× 28 681
Nicole Gormley United States 18 362 0.8× 272 0.9× 397 1.4× 90 0.8× 169 1.8× 53 1.0k
Rob Pieters Netherlands 15 342 0.8× 352 1.2× 266 0.9× 59 0.5× 69 0.7× 27 957
Jill Kolesar United States 19 329 0.8× 296 1.0× 55 0.2× 139 1.3× 89 1.0× 68 948
Andreas Trojan Switzerland 22 741 1.7× 339 1.1× 151 0.5× 295 2.7× 206 2.2× 64 1.8k
Mehrdad Payandeh Iran 16 345 0.8× 208 0.7× 132 0.5× 95 0.9× 93 1.0× 115 917
Bertrand Pourroy France 17 294 0.7× 331 1.1× 49 0.2× 78 0.7× 38 0.4× 47 823
Annie Im United States 13 301 0.7× 242 0.8× 403 1.4× 54 0.5× 139 1.5× 64 851
Basem M. William United States 20 457 1.1× 329 1.1× 316 1.1× 79 0.7× 184 2.0× 96 1.4k

Countries citing papers authored by Sandra Kurtin

Since Specialization
Citations

This map shows the geographic impact of Sandra Kurtin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Kurtin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Kurtin more than expected).

Fields of papers citing papers by Sandra Kurtin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Kurtin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Kurtin. The network helps show where Sandra Kurtin may publish in the future.

Co-authorship network of co-authors of Sandra Kurtin

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Kurtin. A scholar is included among the top collaborators of Sandra Kurtin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Kurtin. Sandra Kurtin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faiman, Beth, et al.. (2023). Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology. Journal of the Advanced Practitioner in Oncology. 14(3). 223–226. 1 indexed citations
2.
Kurtin, Sandra, et al.. (2022). Biomarker Jeopardy. Journal of the Advanced Practitioner in Oncology. 13(3). 292–297.
3.
Sallman, David A., Rafael Bejar, Guillermo Montalban‐Bravo, et al.. (2022). Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning. Leukemia Research Reports. 17. 100328–100328. 1 indexed citations
4.
Kurtin, Sandra, et al.. (2019). Pain Management in the Cancer Survivor. Seminars in Oncology Nursing. 35(3). 284–290. 11 indexed citations
5.
Faiman, Beth, et al.. (2018). Multiple Myeloma Education: Results From the ACE Program’s Digital, Serial Learning Approach. Clinical journal of oncology nursing. 22(5). E120–E126. 1 indexed citations
6.
Kurtin, Sandra, et al.. (2016). The Advanced Practitioner and Collaborative Practice in Oncology.. PubMed Central. 6(6). 515–27. 7 indexed citations
7.
Tinsley, Sara, et al.. (2015). Practical Management of Lenalidomide-Related Rash. Clinical Lymphoma Myeloma & Leukemia. 15. S64–S69. 29 indexed citations
8.
Kurtin, Sandra, et al.. (2014). Implementing Evidence-Based Practice Using an Interprofessional Team Approach. Oncology nursing forum. 41(4). 434–437. 5 indexed citations
9.
Kurtin, Sandra & Beth Faiman. (2013). The Changing Landscape of Multiple Myeloma. Clinical journal of oncology nursing. 17(s6). 7–11. 7 indexed citations
10.
Kurtin, Sandra, et al.. (2013). Caregivers of Multiple Myeloma Survivors. Clinical journal of oncology nursing. 17(s6). 25–32. 24 indexed citations
11.
Lilleby, K, et al.. (2013). Autologous Hematopoietic Stem Cell Transplantation for Patients With Multiple Myeloma. Clinical journal of oncology nursing. 17(s6). 13–24. 9 indexed citations
12.
Murray, Cindy, et al.. (2012). Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: A practice standard for Canadian nurses. Canadian Oncology Nursing Journal. 22(4). 222–227. 2 indexed citations
13.
Mahadevan, Daruka, Donald W. Northfelt, Pavani Chalasani, et al.. (2012). Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma. International Journal of Clinical Oncology. 18(5). 934–941. 18 indexed citations
14.
Kurtin, Sandra. (2012). Myelodysplastic Syndromes. Clinical journal of oncology nursing. 16(0). 5–7. 1 indexed citations
15.
Kurtin, Sandra, C. Knop, & Todd Milliron. (2012). Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions. Journal of the Advanced Practitioner in Oncology. 3(6). 406–10. 11 indexed citations
16.
Lacouture, Mario E., Michael L. Maitland, Siegfried Segaert, et al.. (2010). A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Supportive Care in Cancer. 18(4). 509–522. 107 indexed citations
17.
Kurtin, Sandra. (2009). Systemic Therapies for Squamous Cell Carcinoma of the Head and Neck. Seminars in Oncology Nursing. 25(3). 183–192. 6 indexed citations
18.
Kurtin, Sandra. (2007). Targeting the Epidermal Growth Factor Receptor in Colorectal Carcinoma. Cancer Nursing. 30(4). S1–S9. 4 indexed citations
19.
Dragovich, Tomislav, David S. Mendelson, Sandra Kurtin, et al.. (2006). A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 58(6). 759–764. 106 indexed citations
20.
Kurtin, Sandra. (2006). Advances in the Management of Low-to Intermediate-Risk Myelodysplastic Syndrome: Integrating the National Comprehensive Cancer Network Guidelines. Clinical journal of oncology nursing. 10(2). 197–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Onetto Breakdown of academic impact, for papers by Ruben A. Saez Breakdown of academic impact, for papers by Nicole Gormley Breakdown of academic impact, for papers by Rob Pieters Breakdown of academic impact, for papers by Jill Kolesar Breakdown of academic impact, for papers by Andreas Trojan Breakdown of academic impact, for papers by Mehrdad Payandeh Breakdown of academic impact, for papers by Bertrand Pourroy Breakdown of academic impact, for papers by Annie Im Breakdown of academic impact, for papers by Basem M. William
Rankless by CCL
2026